05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary food preparations for medical purposes; medical
preparations for use as additives for human consumption;
medical preparations and substances; pharmaceutical
preparations.
The present invention relates to compositions comprising herbicidally active compounds (A) and (B), where (A) represents one or more compounds of the general formula (I) or agrochemically compatible salts thereof [component (A)], and (B) represents one or more herbicides [component (B)]. The application also relates to a process and to the use of the herbicidal composition according to the invention for controlling undesirable plants or regulating plant growth.
irir3.4, KCNJ5) inhibitory compounds, the preparation thereof and the use thereof for the treatment and/or prevention of diseases. These compounds can be used for the treatment and/or prevention of cardiovascular disorders. In one Example the disorder can be atrial fibrillation (AF) and/or other related cardiac arrhythmias.
A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
C07K 14/435 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
4.
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS CAPABLE OF ALLEVIATING AND PREVENTING ALLERGIC RHINITIS, AND USE THEREOF
Provided are a bifidobacterium longum subsp. infantis capable of alleviating and preventing allergic rhinitis, and a use thereof, relating to the technical fields of microorganisms and medicine. The bifidobacterium longum subsp. infantis CCFM111 can alleviate allergic reactions in allergic mice, and alleviate and prevent allergic disorders in patients with perennial allergic rhinitis. Specifically: (1) the bifidobacterium longum subsp. infantis CCFM111 alleviates weight loss and symptoms caused by allergies in mice, reduces pulmonary inflammation infiltration, lowers serum OVA-sIgE and total IgE levels, and regulates the expression of pro-inflammatory and anti-inflammatory factors. (2) The bifidobacterium longum subsp. infantis CCFM111 alleviates allergic symptoms and reduces medication scores in patients, increases the proportion of symptom-free days of patients, lowers the serum sIgE levels against dermatophagoides farinae and dermatophagoides pteronyssinus in patients, and regulates the expression of cytokines in the serum and nasal lavage fluid of patients. Therefore, the bifidobacterium longum subsp. infantis CCFM111 has broad prospects for application in the preparation of a product for preventing and/or treating allergic rhinitis.
Systems, methods, and computer programs disclosed herein relate to training and using a machine learning model to predict compositions and/or properties of formulations, in particular of active ingredient formulations.
The present invention relates to the technical field of the marking of articles by means of optically readable codes and of decoding the codes. Such a code is introduced into a surface of an article. The code is decoded on the basis of a transformed captured image of the code. The transformed captured image is generated from at least one captured image of the code using a machine learning model. The model is trained to generate a transformed captured image from at least one captured image and the readout of the optically readable code leads to less decoding errors than the readout of the code in the at least one captured image. The present invention relates to a method for training the machine learning model and to a method, a system and a computer program product for decoding a code using the trained machine learning model.
G06K 7/14 - Methods or arrangements for sensing record carriers by electromagnetic radiation, e.g. optical sensingMethods or arrangements for sensing record carriers by corpuscular radiation using light without selection of wavelength, e.g. sensing reflected white light
The present disclosure relates to monitoring arthropods on the basis of captured images. The subject matter of the present disclosure comprises a device, a system, and a method.
The present invention relates to a process for preparing (4S)-24-chloro-4-ethyl-73-fluoro-35- methoxy-32,5-dioxo-14-(trifluoromethyl)-32H-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola- 2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide (I) from 2,5-dimethoxypyridine (II), 1-(2-bromo- 4-chlorophenyl)-4-(trifluoromethyl)-1H-1,2,3-triazole (IV), 4-amino-2-fluorbenzamide (IX) and (2R)-2-bromobutanoic acid - N-cyclohexylcyclohexanamine (XI).
C07D 401/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
C07C 231/12 - Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
The present invention relates to a process for preparing (4S)-24-chloro-4-ethyl-73-fluoro-35- methoxy-32,5-dioxo-14-(trifluoromethyl)-32HH-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola- 2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide (I) from (Z)-2-bromobut-2-enoic acid (XXII), 4- amino-2-fluorobenzamide (XII) and 4-{5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1- yl]phenyl}-5-methoxypyridin-2(1H)-one (XV) with an enantioselective hydrogenation of the 5 double bond in the last synthesis step.
C07D 401/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
C07C 237/30 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
Medical instruments; medical devices; medical devices for the delivery of contraceptives; contraceptives for the delivery via devices; contraceptives (non-chemical) for the delivery via device; none of the aforementioned goods being Cardiac ablation catheters.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary food preparations for medical purposes; medical
preparations for use as additives for human consumption;
medical preparations and substances; pharmaceutical
preparations.
The invention relates to a process for distillative recovery of 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) from an initial mixture comprising 1,1,1,3,3,3-hexafluoro-2-propanol and at least one 4-substituted 1,2,3,4-tetrahydroquinoline, wherein a protic solvent selected from the group consisting of water, alcohols having a boiling point at 1 bar of 115° C. or less, and mixtures thereof is added to the initial mixture to obtain a distillation mixture, and the distillation mixture is subjected to distillation.
C07C 29/80 - SeparationPurificationStabilisationUse of additives by physical treatment by distillation
17.
BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS
The invention relates to bromine- or iodine-para-substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acid derivatives and their salts, to agents for protecting useful plants or crop plants comprising them, to methods for producing them and to their use as safeners. The present invention relates to protection compounds and agents for useful plants, which compounds and agents comprise specific compounds as safeners for reducing phytotoxic effects of agrochemicals, especially herbicides. The invention relates more particularly to bromine- or iodine-para-substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acid derivatives of the general formula (I) and their salts, to methods for producing them and to the their use as protection compounds (safeners) for useful plants.
A01N 25/32 - Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
18.
SOLVENT-FREE FORMULATIONS OF LOW-MELTING ACTIVE INGREDIENTS
The present disclosure relates to solvent-free aqueous suspension concentrates and to solvent-free solid water-dispersible formulations comprising one or more low-melting active ingredients, and to processes for production thereof. The formulations according to the disclosure are suitable for the field of plant protection.
A01N 25/32 - Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
A01N 47/36 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the group N—CO—N directly attached to at least one heterocyclic ringThio-analogues thereof
What is described herein relates to automated aseptic method for formulation of cells comprising providing a container with a filling volume in the range of between of 0.01-50 ml, filling the container with a cell suspension and a solution, closing the container, mixing the cell suspension and the solution to generate a final suspension, wherein the container is a final product container
The present disclosure relates to the monitoring of arthropods on the basis of captured images. The present disclosure provides a system, a kit and a method. The system comprises a main body (10) having a receiving surface (11) for receiving a sheet provided with adhesive, a holding device (30) for receiving an IoT device comprising a camera, spacer means (40), wherein the spacer means (40) fix the holding device (30) at a distance from the receiving surface (11) of the main body (10), and an enclosure (20) between the spacer means and the main body for protecting the receiving surface from environmental influences. The enclosure (20) and the receiving surface (11) define a volume and/or delimit this volume at least in part. The holding device (30) is outside the volume.
The present embodiments relate to cell confluency estimation and manufacturing. Subject matter of the present embodiments provides computer-implemented methods, computer systems and computer-readable storage media for predicting the results of image-based cell confluency estimation and manufacturing methods.
G06V 10/44 - Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersectionsConnectivity analysis, e.g. of connected components
G06V 10/764 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using classification, e.g. of video objects
G06V 20/69 - Microscopic objects, e.g. biological cells or cellular parts
22.
WET GRANULATION PLATFORM TECHNOLOGY TO MANUFACTURE SOFT TABLETS/CHEWS
A composition including wet granules is provided herein, where the wet granules include pectin, xanthan gum, one or more sweetener, a glycerin-water mixture, and one or more active pharmaceutical ingredient (API), and a lubricant is optionally present on one or more of the wet granules. Also provided herein is a gummy product including pectin, xanthan gum, one or more sweetener, a glycerin-water mixture, and one or more API. Also provided herein is a method of making a gummy product including hydrating a powder blend with a glycerin-water mixture to form wet granules, optionally coating the wet granules with a lubricant, and compressing the wet granules to form the gummy product, where the powder blend includes pectin, xanthan gum, one or more sweetener, and one or more API.
A23G 3/36 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition
A23G 3/42 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition characterised by the carbohydrates used, e.g. polysaccharides
A23G 3/48 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition containing plants or parts thereof, e.g. fruits, seeds, extracts
The present invention covers the use of chymase inhibitors in general and more in particular substituted bicyclically substituted uracils of general formula (I) as described and defined herein, and 3-methylbenzo-[b]thiophene)-2-sulfonamido derivatives of general formula (II) for manufacturing pharmaceutical compositions for the treatment or prophylaxis of stroke, pulmonary embolism, deep or superficial vein thrombosis, thrombotic microangiopathy, thrombotic microangiopathy in hypercoagulable states after infection, inflammation, transplantation, disseminated intravascular coagulation, vaccine-induced immune thrombotic thrombocytopenia, vascular access site thrombosis or occlusion.
The present disclosure relates to monitoring arthropods on the basis of captured images. The subject matter of the present disclosure is a computer-implemented method, a device, and a computer program.
The present disclosure relates to heterocyclyl pyridazine compounds, processes and intermediates for their preparation as well as the uses thereof for controlling phytopathogenic microorganisms, such as phytopathogenic fungi.
A01N 43/88 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms, as ring hetero atoms six-membered rings with three ring hetero atoms
C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 413/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 417/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Provided herein is a system for delivering a therapeutic composition to a patient, including: a container configured to hold a therapeutic composition; at least one powered drive in operative connection with the container; a plurality of sensors including at least two of (i) a pressure sensor, (ii) a flow sensor, (iii) a counting sensor, (iv) a site sensor, (v) a temperature sensor, (vi) a chemical sensor, and (vii) at least one physiological sensor; and at least one processor programmed or configured to receive the data from the plurality of sensors and, control the at least one powered drive to inject the therapeutic composition into the patient at a desired flow rate whose magnitude depends on the data received from the plurality of sensors.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
30.
SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR OCCLUSION DETECTION AND IMPROVED PRESSURE LIMITING BEHAVIOR FOR FLUID INJECTOR DEVICES
A system and computer program product are disclosed for occlusion detection and/or pressure limiting in a fluid injector system. A fluid injector system includes at least one fluid injector device, one or more drive components, and a control device. The control device includes at least one processor programmed provide instructions to the fluid injector system to deliver fluid at a predetermined fluid flow rate, determine a first fluid pressure measurement within the fluid injector device at a first time, determine a second fluid pressure measurement at a second time, determine a pressure differential between the first fluid pressure measurement and the second fluid pressure measurement, calculate a change in compliance volume based on the determined pressure differential, compare the calculated change in compliance volume with the predetermined fluid flow rate, repeat the steps throughout the fluid injection procedure, and determine whether an occlusion or a partial occlusion has occurred.
The present disclosure relates to new manganese (Mn2+) chelate compounds, to methods of preparing said compounds, to the use of said compounds as contrast agents in diagnostic imaging such as magnetic resonance imaging (MRI) and to their use in a mammalian body.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Described herein are DMSO formulations and methods for cell therapy. Methods of treating a cell with these formulations are also provided. The embodiments provide a formulation that maintains the suspension and viability of a T-cell during cell therapy (CT) manufacturing and through a cryopreservation thaw cycle, including dimethyl sulfoxide (DMSO); sucrose or trehalose; human semm albumin (HSA); and dextran 40 or hydroxyethyl starch (HES). wherein the formulation maintains the suspension and viability of T-cells during CT manufacturing and through a cryopreservation thaw cycle. The embodiments provide a method for maintaining a suspension and cell viability, including subjecting a T-cell during a cell therapy manufacturing cryopreservation thaw cycle to a formulation including DMSO; sucrose or trehalose; human semm albumin (HSA); and polysaccharide or HES wherein the formulation maintains the suspension and viability of a T-cell during cell therapy manufacturing and through a cryopreservation thaw cycle.
PaenibacillusPaenibacillus bacterial strains are engineered to express or overexpress (i) one or more proteins (pyruvate ferredoxin oxidoreductase, flavodoxin, and/or ferredoxin) involved in the electron transport chain, (ii) the DUF protein and/or (iii) gene products of the suf operon. This enables a greater rate/level of nitrogen fixation by the diazotrophic bacteria. The engineered bacteria are introduced to agricultural plants, or seeds for growing such, forming a symbiotic relationship that results in increased nitrogen availability to the plant and improved plant agronomic traits.
Herbicide/safener combinations based on herbicides of the class of chiral N-(1,3,4-oxadiazol-2-yl)phenylcarboxamides and salts thereof The present invention provides combinations comprising one or more component(s) (A) that are effective as safeners and one or more herbicidally active compounds (component (B)), wherein component (B) represents one or more compounds of the general formula (I) or agrochemically acceptable salts thereof
A01N 43/82 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms, as ring hetero atoms five-membered rings with three hetero atoms
The present invention relates to an inserter for an intrauterine system comprising a handle (3), and an insertion tube (6) having a first end and a second end, and being arranged in connection with the handle. The inserter is characterized in that the first end of the insertion tube (6) comprises at least one frame slot for receiving a frame of the intrauterine system. The invention also relates to a kit comprising an inserter according to the present invention and an intrauterine system, wherein the intrauterine system (1) comprises a therapeutic component (1b) and a continuous, closed frame (1a), the therapeutic component (1b) being connected to the frame (1a) at least one point, and therapeutic component (1b) of the intrauterine system (1) is at least mainly arranged inside the first end of the insertion tube (6) and the frame (1a) of the intrauterine system (1) is at least mainly arranged outside the first end of the insertion tube (6).
C07D 261/04 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
62.
METHOD FOR ASSESSING THE POSSIBILITY TO PERFORM A SPRAY APPLICATION
The present invention relates to a computer-implemented method for assessing the possibility to perform a spray application for a crop with at least one Crop Protection Product (CPP) on an agricultural field. The method uses the information of the Fractional Vegetation Cover (FVC) on the agricultural field to determine possibility to perform a spray application. The present invention also relates to a computer program product, which when executed by a processor is configured to carry out the steps of the method.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations, for use in the following fields: Treatment of oncological indications; Pharmaceutical preparations, for use in the following fields: Treatment and prevention of cardiovascular diseases; Pharmaceutical preparations for use in the following fields: Treatment and prevention of inflammatory indications; Pharmaceutical preparations for use in the following fields: Treatment of Parkinson's disease.
The present invention relates to novel active compound combinations comprising the compound of the formula (I) and at least one further active compound which combinations are highly suitable for controlling animal and microbial pests.
A01N 43/90 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
A01N 43/40 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
The present disclosure relates to the monitoring of arthropods on the basis of captured images. The subject matter of the present disclosure includes a folding sheet, a housing, a system, methods and uses.
The present application relates to a device to longitudinal clean cutting of a plant stem, e. g. of cereal crops stems, such as wheat or corn stems, and a method of use thereof. The solution is implemented as a portable device.
According to an aspect of the present invention, there is provided an apparatus for ultrasonic welding of a removal thread (1) of an intrauterine system (2). The apparatus comprises a welding jig (3) comprising a welding groove (4), the welding groove having a length Lg, a width Wg and a depth Dg and a bottom (5) with concave shape. The apparatus further comprises a sonotrode (6) having a length Ls that is 150-220% of Lg, a width Ws of a welding tip (7) of the sonotrode that is 80-98% of Wg and a depth Ds. Further, the welding tip of the sonotrode has a concave shape.
The present disclosure relates to the monitoring of arthropods on the basis of captured images. The subject matter of the present disclosure includes a computer-implemented method, a computer system, a computer program, and a device.
The present disclosure relates to the monitoring of arthropods on the basis of captured images. The subject matter of the present disclosure includes an IoT device, a system, and a method.
A system (100, 200) is provided for priming seeds. In one embodiment, the system (100, 200) generally includes one or more priming vessels (108), each including a reaction chamber (108, 308) holding a priming liquid, and a coolant chamber (310) surrounding the priming chamber (108, 308, 310). The coolant chamber (310) is in fluid communication with a temperature regulating element. The priming system (100, 200) further includes a mixing unit suspended within an interior of the priming chamber (108, 308, 310). The mixing unit includes a connecting rod (304, 506) extending within the priming chamber (108, 308, 310). The connecting rod (304, 506) includes a distal end and a proximal end. The mixing unit further includes a mixing plate (314, 400, 502, 504) connected to the distal end of the connecting rod (304, 506) and submerged within the priming liquid. The mixing plate (314, 400, 502, 504) includes a plurality of conical holes (402), and, when oscillated, is configured to circulate the priming liquid within the priming chamber (108, 308, 310).
The present invention relates: to a tablet formulation comprising crystalline Hydrate 1 Modification A form of the compound 3-(3-chloro-2-methoxy-anilino)-2-[3-[[(2S)-1,4-dioxan-2-yl]methoxy]-4-pyridyl]-1,5,6,7- [Image disponible dans le document PDF, Image available in the PDF document] (A), • wherein the content of water is greater than 0% and less than or equal to 4%, i.e. by weight, of the total weight of said compound of formula (A); to methods of preparing said tablet formulation, and to uses of said tablet formulation in the prophylaxis and/or treatment of diseases.
A61K 31/4412 - Non-condensed pyridinesHydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61P 35/02 - Antineoplastic agents specific for leukemia
77.
HERBICIDE/SAFENER COMBINATIONS BASED ON SAFENERS FROM THE CLASS OF SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY] ACETIC ACIDS AND HERBICIDES FROM THE CLASS OF SUBSTITUTED CYCLIC DIONES AND THE SALTS THEREOF
Herbicide/safener combinations based on safeners from the class of substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy] acetic acids and herbicides from the class of substituted cyclic diones and the salts thereof. The present invention provides combinations comprising one or more component(s) (A) that are effective as safeners and one or more herbicidally active compounds (component (B)), wherein component (A) represents one or more compounds of the general formula (I) or agrochemically acceptable salts thereof and component (B) represents one or more herbicides. The application further relates to a method and to the use of the herbicide/safener combinations of the invention for controlling harmful plants or for regulating growth.
A01N 25/32 - Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
A01N 35/06 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinoneDerivatives thereof, e.g. ketals
A01N 43/16 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom six-membered rings with oxygen as the ring hetero atom
A01N 43/42 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
A01N 43/44 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom three- or four-membered rings
HERBICIDE/SAFENER COMBINATIONS BASED ON SAFENERS FROM THE CLASS OF SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY] ACETIC ACIDS AND HERBICIDES FROM THE CLASS OF SUBSTITUTED CYCLIC DIONES AND THE SALTS THEREOF
Herbicide/safener combinations based on safeners from the class of substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy] acetic acids and herbicides from the class of substituted cyclic diones and the salts thereof The present invention provides combinations comprising one or more component(s) (A) that are effective as safeners and one or more herbicidally active compounds (component (B)), wherein component (A) represents one or more compounds of the general formula (I) or agrochemically acceptable salts thereof and component (B) represents one or more herbicides. The application further relates to a method and to the use of the herbicide/safener combinations of the invention for controlling harmful plants or for regulating growth.
A01N 25/32 - Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
A01N 35/06 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinoneDerivatives thereof, e.g. ketals
The present invention relates: to the crystalline Hydrate 1 Modification A form of the compound 3-(3-chloro-2-methoxy- anilino)-2-[3-[[(2S)-1,4-dioxan-2-yl]methoxy]-4-pyridyl]-1,5,6,7-tetrahydropyrrolo[3,2- c)pyridine-4-one of formula (A): [Image disponible dans le document PDF, Image available in the PDF document] (A), wherein the content of water is greater than 0 % (w/w) and 4.0 % (w/w); to a method of preparing said crystalline Hydrate 1 Modification A form of said compound of formula (A) and to intermediate compounds used in said method; to pharmaceutical compositions and combinations comprising said crystalline Hydrate 1 Modification A form of said compound of formula (A); and lacktriangle to said crystalline Hydrate 1 Modification A form of the compound of formula (A), and to pharmaceutical compositions or combinations comprising same for use in the treatment or prevention of a cancer, such as lung cancer, particularly non-small cell lung carcinoma.
A61P 35/02 - Antineoplastic agents specific for leukemia
C07C 217/84 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
C07C 331/28 - Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
C07D 211/80 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
The present invention relates to a hybrid Solanum lycopersicum plant comprising in its genome at least one copy of the Rug-1 resistance gene, wherein said Rug-1 resistance gene is capable of conferring a Tomato Brown Rugose Fruit Virus (ToBRFV) tolerance/resistance phenotype. The present invention further relates to a seed produced by the plant according to the present invention, a seed from which a plant according to present invention can be grown, a fruit produced by a plant according to the present invention and a part of a plant according to the present invention. The present invention further relates to a method of identifying and/or selecting a plant or plant part according to the present invention. The present invention further relates to a method for producing a Solanum lycopersicum plant having a ToBRFV tolerance/resistance phenotype according to the present invention. The present invention further relates to a method for enhancing the ToBRFV tolerance/resistance phenotype of a Solanum lycopersicum plant, the use of the Rug-1 resistance gene according to the present invention for enhancing the ToBRFV tolerance/resistance phenotype in a Solanum lycopersicum plant and the use of a genetic marker specific of the Rug-1 resistance gene according to the present invention for selecting a Solanum lycopersicum plant having an enhanced ToBRFV tolerance/resistance phenotype.
What is described herein relates to a method for generating micro-particles comprising the steps of providing an aqueous nanosuspension comprising nanoparticles as seeding material characterized by a nano-particle size in at least one of length, diameter or height of a d90 in the range of 10 nm and 999 nm as measured by Dynamic Light Scattering (DLS), laser diffraction or electron microscopy and at least one stabilizer, providing a homogenous saturated solution of a substance in a crystallization medium where said substance is the same substance as the substance constituting the nanoparticles in the nanosuspension mixing the homogenous saturated solution and the aqueous nanosuspension comprising nanoparticles as seeding material at a supersaturation level with respect to the substance in the range of 1 and 1000 optionally isolating micro-particles.
The present invention relates to the technical field of radiology. The invention relates to a new approach for training a machine learning model for generating synthetic radiological images on the basis of measured radiological images and to the use of the trained machine learning model for generating synthetic radiological images.
The present invention relates to a new class of compounds of general formula (I), to the metal chelates with a metal ion suitable for computed tomography thereof, to the Gd3+ chelate complexes thereof, to methods of preparing said compounds, and to the use of said compounds as contrast agents in diagnostic imaging, such as in magnetic resonance imaging (MRI) and computed tomography (CT).
The present invention relates to a new class of compounds of general formula (I), to the metal chelates with a metal ion suitable for computed tomography thereof, to the Gd3+ chelate complexes thereof, to methods of preparing said compounds, and to the use of said compounds as contrast agents in diagnostic imaging, such as in magnetic resonance imaging (MRI) and computed tomography (CT).
The present application relates to the use of substituted indazoles for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially for treatment and/or prophylaxis of atopic dermatitis, Flea Allergy Dermatitis, inflammatory bowel disease, osteoarthritis and inflammatory pain, non-infectious recurrent airway disease, insect hypersensitivity, asthma, respiratory disease, mastitis and endometritis in animals.
C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
86.
DETECTION OF AN EVENT IN A DEVICE FOR MONITORING ARTHROPODS
The present invention relates to monitoring arthropods on the basis of image captures. A device (1) for monitoring arthropods comprises a camera, wherein the camera is configured to generate an image capture of a collecting region for arthropods. The device also comprises: a transmitting unit for transmitting information to a separate computer system; a sensor; and a control unit. The control unit is configured: to receive, in an idle state, a signal from the sensor, wherein the signal indicates a movement and/or change in position of the device (1); to assign, in the idle state, the signal to an event; and to transfer the device (1) from the idle state into an active state in response to the assignment of the signal to the event, only if the signal or values derived therefrom correspond to a predefined event profile. The present invention also relates to a computer-implemented method and a computer program.
The invention relates to the monitoring of arthropods on the basis of captured images. The disclosed subject matter is a computer-implemented method, an apparatus and a computer program.
The invention relates to the monitoring of arthropods on the basis of captured images. The disclosed subject matter is a computer-implemented method, an apparatus and a computer program.
The invention relates to a computer-implemented method for the image-based identification and classification of at least one plant in an agricultural field. The invention also relates to a device for dispensing a liquid onto at least one part of an agricultural field on the basis of the identified and classified information about the plants, and to a computer-readable storage medium on which the computer-implemented method is encoded.
C07C 67/343 - Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisationPreparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by change of size of the carbon skeleton by increase in the number of carbon atoms
C07C 69/732 - Esters of carboxylic acids having esterified carboxyl groups bound to acyclic carbon atoms and having any of the groups OH, O-metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
The present invention relates to pharmaceutical compositions comprising contrast agents, to methods for preparing said pharmaceutical compositions and to their use for radiological imaging.
A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
The present invention relates to the generation and storage and/or transmission of images of a collection area in which one or more arthropods may be located, for the purpose of detecting, identifying and/or quantifying arthropods. The present invention also relates to a computer-implemented method, to an apparatus and to a computer program.
H04N 19/117 - Filters, e.g. for pre-processing or post-processing
H04N 19/167 - Position within a video image, e.g. region of interest [ROI]
H04N 19/17 - Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding the unit being an image region, e.g. an object
H04N 19/172 - Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding the unit being an image region, e.g. an object the region being a picture, frame or field
H04N 19/85 - Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using pre-processing or post-processing specially adapted for video compression
